Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Iowa State University, Ames, IA, 50011, USA.
Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA, 50011, USA.
Prev Vet Med. 2021 Mar;188:105250. doi: 10.1016/j.prevetmed.2020.105250. Epub 2021 Jan 2.
Distinct from tests used in diagnostics, tests used in surveillance must provide for detection while avoiding false alarms, i.e., acceptable diagnostic sensitivity but high diagnostic specificity. In the case of the reproductive and respiratory syndrome virus (PRRSV), RNA detection meets these requirements during the period of viremia, but antibody detection better meets these requirements in the post-viremic stage of the infection. Using the manufacturer's recommended cut-off (S/P ≥ 0.4), the diagnostic specificity of a PRRSV oral fluid antibody ELISA (IDEXX Laboratories, Inc., Westbrook, ME, USA) evaluated in this study was previously reported as ≥ 97 %. The aim of this study was to improve its use in surveillance by identifying a cut-off that would increase diagnostic specificity yet minimally impact its diagnostic sensitivity. Three sample sets were used to achieve this goal: oral fluids (n = 596) from pigs vaccinated with a modified live PRRSV vaccine under experimental conditions, field oral fluids (n = 1574) from 94 production sites of known negative status, and field oral fluids (n = 1380) from 211 sites of unknown PRRSV status. Based on the analysis of samples of known status (experimental samples and field samples from negative sites), a cut-off of S/P ≥ 1.0 resulted in a diagnostic specificity of 99.2 (95 % CI: 98.8, 99.7) and a diagnostic sensitivity of 96.5 (95 % CI: 85.2, 99.2). Among 211 sites of unknown status, 81 sites were classified as antibody positive using the manufacturer's cut-off; 20 of which were reclassified as negative using a cut-off of S/P ≥ 1.0. Further analysis showed that these 20 sites had a small proportion of samples (18.0 %) with S/P values just exceeding the manufacturer's cut-off (x̄ = 0.5). Whereas the remainder of positive sites (n = 61) had a high proportion of samples (76.3 %) with high S/P values (x̄ = 6.6). Thus, the manufacturer's cut-off (S/P ≥ 0.4) is appropriate for diagnostic applications, but a cut-off of S/P ≥ 1.0 provided the higher specificity required for surveillance. A previously unreported finding in this study was a statistically significant association between unexpected reactors and specific production sites and animal ages or stages. While beyond the scope of this study, these data suggested that certain animal husbandry or production practices may be associated with non-specific reactions.
与诊断中使用的检测不同,监测中使用的检测必须能够在避免假警报的情况下进行检测,即具有可接受的诊断敏感性和高诊断特异性。在生殖和呼吸综合征病毒 (PRRSV) 的情况下,RNA 检测在病毒血症期间符合这些要求,但抗体检测在感染的病毒血症后阶段更好地符合这些要求。在本研究中评估的 PRRSV 口腔液抗体 ELISA(IDEXX Laboratories,Inc.,缅因州西布鲁克)使用制造商推荐的截断值(S/P≥0.4),其诊断特异性先前报道为≥97%。本研究的目的是通过确定一个既能提高诊断特异性又能最小化诊断敏感性的截断值来改进其在监测中的应用。为了实现这一目标,使用了三组样本:在实验条件下用改良活 PRRSV 疫苗接种的猪的口腔液(n=596)、来自已知阴性状态的 94 个生产场所的现场口腔液(n=1574)和来自 211 个未知 PRRSV 状态的现场口腔液(n=1380)。基于对已知状态样本的分析(实验样本和来自阴性场所的现场样本),S/P≥1.0 的截断值导致诊断特异性为 99.2%(95%CI:98.8%,99.7%)和诊断敏感性为 96.5%(95%CI:85.2%,99.2%)。在 211 个未知状态的场所中,81 个场所使用制造商的截断值被归类为抗体阳性;其中 20 个使用 S/P≥1.0 的截断值重新归类为阴性。进一步分析表明,这些 20 个场所仅有一小部分样本(18.0%)的 S/P 值刚刚超过制造商的截断值(x̄=0.5)。而其余阳性场所(n=61)有很大一部分样本(76.3%)的 S/P 值很高(x̄=6.6)。因此,制造商的截断值(S/P≥0.4)适用于诊断应用,但 S/P≥1.0 的截断值为监测提供了所需的更高特异性。本研究中一个以前未报道的发现是,在意外反应者和特定生产场所、动物年龄或阶段之间存在统计学上显著的关联。虽然超出了本研究的范围,但这些数据表明,某些饲养或生产实践可能与非特异性反应有关。